current
prophylact
therapeut
strategi
target
human
influenza
virus
includ
vaccin
antivir
given
variabl
rate
vaccin
efficaci
antivir
resist
altern
strategi
urgent
requir
improv
diseas
outcom
describ
use
hiseq
deep
sequenc
analyz
host
gene
express
primari
human
alveolar
epitheli
type
ii
cell
infect
highli
pathogen
avian
influenza
viru
hour
postinfect
host
gene
significantli
upregul
includ
cell
adhes
molecul
upregul
block
presenc
reactiv
oxygen
speci
inhibitor
apocynin
viru
infect
stimul
significantli
higher
protein
express
compar
low
pathogen
viru
suggest
key
role
influenza
viru
pathogen
furthermor
silenc
endogen
result
reduc
level
proinflammatori
cytokinechemokin
product
well
reduc
level
viru
replic
follow
infect
studi
provid
evid
involv
clinic
relev
model
infect
may
assist
develop
hostori
antivir
strategi
import
highli
pathogen
avian
influenza
viru
continu
pose
potenti
pandem
threat
therapeut
strategi
enhanc
host
immun
respons
promot
clearanc
influenza
viru
infect
urgent
need
significantli
upregul
primari
alveolar
epitheli
type
ii
cell
infect
viru
one
human
gene
identifi
use
hiseq
deep
sequenc
analysi
upregul
follow
infect
although
known
multifacet
immun
regulatori
role
littl
known
contribut
host
immun
result
present
show
right
reserv
reus
allow
without
permiss
regul
innat
immun
respons
clinic
relev
vitro
human
model
infect
influenza
virus
caus
acut
highli
contagi
season
respiratori
diseas
age
group
million
case
sever
influenzarel
ill
death
report
everi
year
addit
constant
season
outbreak
highli
pathogen
avian
influenza
hpai
strain
remain
ongo
pandem
threat
recent
figur
show
confirm
laboratori
infect
mortal
rate
import
note
human
littl
preexist
immun
toward
avian
influenza
viru
strain
moreov
commerci
avail
human
vaccin
given
potenti
virus
trigger
pandem
urgent
need
develop
novel
therapeut
intervent
combat
known
defici
abil
control
outbreak
current
season
influenza
viru
prophylact
therapeut
strategi
involv
use
vaccin
antivir
vaccin
efficaci
highli
variabl
evidenc
particularli
sever
epidem
frequent
reformul
vaccin
requir
combat
ongo
mutat
influenza
viru
genom
addit
antivir
resist
report
mani
circul
strain
includ
avian
influenza
viru
emerg
influenza
virus
also
shown
target
hijack
multipl
host
cellular
pathway
promot
surviv
replic
increas
evid
suggest
target
host
pathway
influenc
viru
replic
inflamm
immun
patholog
altern
intervent
strategi
base
modul
host
respons
could
use
supplement
current
prophylact
therapeut
protocol
impact
influenza
viru
infect
rel
well
studi
anim
model
human
cellular
respons
poorli
defin
due
lack
avail
human
autopsi
materi
especi
hpai
virusinfect
patient
present
studi
character
influenza
viru
infect
primari
human
alveolar
epitheli
type
ii
atii
cell
isol
normal
human
lung
tissu
donat
patient
undergo
lung
resect
atii
cell
physiolog
relev
infect
model
major
target
influenza
virus
enter
respiratori
tract
human
host
gene
express
follow
hpai
viru
infect
primari
atii
cell
analyz
use
illumina
hiseq
deep
sequenc
order
gain
better
understand
mechan
underli
modul
host
immun
inflammatori
environ
also
analyz
chang
gene
express
follow
hpai
infect
presenc
reactiv
oxygen
speci
inhibitor
ro
apocynin
compound
known
interfer
nadph
oxidas
subunit
assembl
hiseq
analysi
describ
herein
focus
differenti
regul
gene
follow
infect
identifi
carcinoembryonicantigen
cea
relat
cell
adhes
molecul
key
gene
interest
also
known
bgp
express
epitheli
endotheli
cell
well
b
cell
cell
neutrophil
nk
cell
macrophag
dendrit
cell
dc
human
shown
act
receptor
sever
human
bacteri
fungal
pathogen
includ
haemophilu
influenza
escherichia
coli
salmonella
typhi
candida
albican
yet
implic
viru
entri
howev
emerg
evid
suggest
involv
host
immun
enhanc
lymphocyt
express
detect
pregnant
women
infect
cytomegaloviru
cervic
tissu
isol
patient
papillomaviru
infect
eleven
splice
variant
report
human
isoform
uniprot
differ
number
immunoglobulinlik
domain
present
presenc
absenc
transmembran
domain
andor
length
cytoplasm
tail
ie
l
long
short
fulllength
human
protein
consist
four
extracellular
domain
one
extracellular
immunoglobulin
variableregionlik
igvlik
domain
three
immunoglobulin
constant
region
domain
transmembran
domain
long
l
cytoplasm
tail
long
cytoplasm
tail
contain
two
immunoreceptor
tyrosinebas
inhibitori
motif
itim
absent
short
form
tabl
hpai
infect
atii
cell
activ
antivir
state
evidenc
upregul
numer
interferoninduc
gene
gene
associ
pathogen
defens
cell
prolifer
apoptosi
metabol
tabl
tabl
apocynin
alonetr
ha
group
larg
number
gene
also
significantli
regul
gene
downregul
gene
fig
tabl
rel
control
group
whilst
subset
gene
differenti
express
hd
ha
group
major
gene
downregul
apocynin
includ
involv
cell
adhes
regul
cell
migrat
go
regul
cell
prolifer
signal
transduct
go
oxidationreduct
process
tabl
nd
vs
ha
downregul
total
gene
upregul
follow
infect
nd
vs
hd
fig
overlap
two
list
gene
nd
vs
hd
hd
vs
ha
gene
shown
downregul
presenc
apocynin
fig
overlap
three
list
gene
nd
vs
hd
hd
vs
ha
nd
vs
ha
gene
gene
present
three
list
fig
indic
gene
significantli
inhibit
apocynin
level
still
significantli
higher
uninfect
cell
gene
includ
involv
influenza
immun
pml
jakstat
signal
cytokinecytokin
receptor
interact
rigilik
receptor
signal
tabl
therefor
critic
immun
respons
induc
follow
infect
dampen
follow
apocynin
treatment
remain
gene
exclud
nd
vs
ha
list
significantli
inhibit
apocynin
level
similar
uninfect
control
cell
fig
gene
reduc
apocynin
basal
level
involv
signal
myc
vegfc
cytokinecytokin
receptor
interact
vegfc
tnf
signal
cflar
vegfc
apoptosi
cflar
ctso
ctss
tabl
consist
role
apocynin
reduc
inflamm
apoptosi
overlap
three
list
gene
nd
vs
hd
hd
vs
ha
nd
vs
ha
eleven
gene
found
three
comparison
suggest
gene
upregul
follow
infect
significantli
reduc
apocynin
treatment
level
lower
observ
uninfect
control
cell
fig
among
inflammatori
cytokineschemokin
gene
includ
axl
member
tam
receptor
famili
receptor
tyrosin
kinas
stimul
ifn
gene
tabl
qrtpcr
analysi
fig
apocynin
treatment
increas
mrna
express
fig
although
hiseq
analysi
detect
statist
signific
increas
follow
apocynin
treatment
foldchang
gene
express
similar
hd
ha
group
vs
fig
transcript
also
found
significantli
increas
follow
infect
alon
follow
hiseq
analysi
increas
apocynin
treatment
fig
contrast
mrna
slightli
increas
sampl
analyz
qrtpcr
fig
apocynin
compound
inhibit
express
ro
shown
influenc
specif
respons
vitro
vivo
although
viru
titer
affect
apocynin
treatment
vitro
antivir
activ
observ
vivo
mice
infect
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
low
pathogen
viru
hiseq
analysi
hpai
viru
gene
transcript
fig
show
although
trend
increas
influenza
viru
gene
express
follow
apocynin
treatment
influenza
nonstructur
ns
gene
express
statist
signific
enrich
antivir
immun
respons
gene
hpai
atii
cell
go
enrich
analysi
perform
gene
significantli
upregul
follow
hpai
infect
atii
cell
presenc
absenc
apocynin
identifi
overpres
go
term
mani
gene
broadli
involv
defens
respons
respons
extern
biotic
stimulu
immun
system
process
cytokinemedi
signal
pathway
type
interferon
signal
pathway
tabl
tabl
addit
mani
gene
map
metabol
pathway
cytokinecytokin
receptor
interact
influenza
tnf
signal
jakstat
signal
tabl
howev
gene
pathway
inhibit
apocynin
treatment
mention
tabl
affect
infect
fig
also
worth
note
read
obtain
fpkm
fpkm
uninfect
atii
cell
fig
b
consist
normal
express
pattern
human
lung
tissu
although
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
form
heterodim
higher
basal
express
atii
cell
may
explain
express
alter
infect
apocynin
treatment
significantli
reduc
transcript
level
fig
fig
express
variant
atii
andor
cell
character
use
pcr
use
primer
pair
design
specif
detect
variant
tabl
differ
protein
level
observ
variou
moi
protein
express
hpi
significantli
higher
observ
hpi
fig
confirm
upregul
protein
express
follow
infect
low
pathogen
viru
cell
protein
express
examin
primari
human
atii
cell
infect
hpai
compar
viru
infect
fig
lower
moi
hpai
test
due
strong
cytopathogen
effect
caus
higher
moi
endogen
protein
level
significantli
elev
atii
cell
three
moi
test
similar
level
protein
express
observ
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
moi
higher
hpi
compar
hpi
fig
hpai
viru
infect
moi
stimul
higher
endogen
level
protein
express
compar
low
pathogen
viru
infect
moi
maximum
increas
induc
moi
hpi
compar
moi
suggest
possibl
role
influenza
viru
pathogen
fig
data
shown
protein
express
reduc
approxim
atii
cell
follow
transfect
compar
sinegtransfect
cell
fig
import
note
antibodi
detect
l
isoform
base
epitop
inform
provid
abcam
therefor
observ
reduct
protein
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
express
attribut
mainli
abolish
isoform
increas
dose
pmol
downregul
protein
express
cell
pmol
chosen
subsequ
knockdown
studi
atii
cell
fig
function
consequ
knockdown
examin
atii
cell
follow
infect
tnf
product
analyz
atii
cell
use
qrtpcr
atii
fig
cell
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
modul
reactiv
oxygen
speci
ro
reduc
inflamm
inhibit
mitogen
rafmekerk
kinas
cascad
activ
suppress
viral
replic
host
target
strategi
offer
altern
current
intervent
focus
target
viru
present
studi
analyz
human
host
gene
express
profil
follow
hpai
infect
treatment
antioxid
apocynin
expect
gene
significantli
upregul
follow
infect
involv
biolog
process
includ
cytokin
signal
immun
apoptosi
addit
gene
also
involv
regul
protein
phosphoryl
cellular
metabol
cell
prolifer
thought
exploit
virus
replic
apocynin
treatment
antivir
tabl
provir
impact
fig
surpris
ro
potent
microbicid
agent
well
import
immun
signal
molecul
differ
concentr
hand
apocynin
treatment
reduc
inflamm
unavoid
impact
cellular
defens
respons
cytokin
product
cytokinemedi
signal
importantli
critic
antivir
respons
compromis
ie
express
pattern
recognit
receptor
eg
rigi
tlr
downregul
tabl
given
signific
interfer
influenza
virus
host
immun
focus
attent
key
regul
immun
respons
hiseq
analysi
identifi
cell
adhes
molecul
critic
regul
immun
knockdown
endogen
reduc
inflammatori
cytokinechemokin
product
also
inhibit
viru
replic
infect
result
signific
upregul
number
inflammatori
cytokineschemokin
gene
includ
axl
sting
significantli
reduc
apocynin
treatment
level
lower
observ
uninfect
cell
tabl
previous
demonstr
treatment
mice
antiaxl
antibodi
significantli
reduc
lung
inflamm
viru
titer
sting
shown
import
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
promot
antivir
respons
stingknockout
cell
produc
less
type
ifn
follow
influenza
viru
infect
reduct
sting
gene
express
antivir
factor
eg
tabl
apocynin
may
part
explain
slight
increas
transcript
level
influenza
gene
ns
gene
significantli
upregul
follow
apocynin
treatment
fig
result
also
suggest
apocynin
treatment
may
reduc
inflamm
apoptosi
inde
antiinflammatori
antiapoptot
effect
apocynin
shown
previous
number
diseas
model
includ
diabet
mellitu
could
suggest
possibl
upregul
inhibit
nk
activ
may
novel
uncharacter
immun
evas
strategi
employ
influenza
virus
laboratori
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
support
notion
observ
differ
apoptosi
cell
follow
transfect
sineg
mocktransfect
cell
use
flow
cytometrybas
annexin
stain
data
shown
studi
togeth
find
serv
highlight
emerg
role
ceacam
influenza
viru
infect
molecular
mechan
action
follow
infect
also
explor
cell
use
low
pathogen
viru
papillomaviru
import
determin
whether
common
mechan
action
attribut
order
determin
function
signific
establish
could
use
target
develop
panantivir
agent
furthermor
shown
isoform
solubl
isoform
also
regulatori
effect
stimulatori
inhibitori
isoform
although
domin
isoform
involv
isoform
influenza
immun
also
investig
especi
infect
increas
mrna
express
level
sever
variant
fig
summari
molecul
cell
surfac
particularli
attract
candid
therapeut
develop
drug
need
cross
cell
membran
order
effect
target
hostencod
gene
combin
current
antivir
vaccin
may
way
reduc
morbid
mortal
associ
influenza
viru
infect
studi
clearli
demonstr
increas
express
observ
primari
human
atii
cell
infect
highli
pathogen
influenza
viru
importantli
knockdown
express
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
dnase
mgml
roch
diagnost
min
singl
cell
suspens
obtain
filtrat
cell
strainer
cell
allow
attach
petri
dish
mixtur
medium
gibco
small
airway
growth
medium
sagm
medium
lonza
contain
fetal
calf
serum
fc
mgml
dnase
hour
nonadher
cell
includ
atii
cell
collect
subject
centrifug
g
min
discontinu
percol
densiti
gradient
gml
purifi
atii
cell
interfac
two
densiti
gradient
collect
wash
hbss
resuspend
sagm
media
supplement
charcoalfilt
fc
gibco
unitsml
penicillin
streptomycin
gibco
prior
plate
polyest
transwel
insert
pore
corn
coat
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
type
iv
human
placenta
collagen
mgml
sigma
cellscm
cell
cultur
liquidcov
condit
humidifi
incub
co
growth
medium
chang
everi
hour
cultur
condit
encourag
atii
cell
grow
differenti
alveolar
epitheli
cell
trypsin
worthington
includ
media
postinocul
assist
replic
viru
titer
determin
use
standard
plaqu
assay
use
mdck
cell
previous
describ
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rna
extract
qualiti
control
qc
hiseq
analysi
atii
cell
three
individu
donor
use
hiseq
analysi
total
rna
extract
cell
use
rneasi
mini
kit
qiagen
influenzainfect
cell
wash
pb
three
time
cell
lyse
rlt
buffer
supplement
gibco
cell
lysat
homogen
qiashredd
column
follow
oncolumn
dna
digest
rnasefre
dnase
set
qiagen
rna
extract
accord
manufactur
instruct
initi
qc
conduct
ensur
quantiti
qualiti
rna
sampl
hiseq
analysi
met
follow
criteria
rna
sampl
ratio
measur
nanodrop
tm
spectrophotomet
thermo
scientif
sampl
concentr
minimum
rna
analyz
agaros
gel
electrophoresi
rna
integr
qualiti
valid
presenc
sharp
clear
band
ribosom
rna
ratio
along
absenc
genom
dna
degrad
rna
part
initi
qc
indic
consist
infect
parallel
quantit
realtim
revers
transcriptas
pcr
qrtpcr
perform
previous
describ
measur
mrna
express
suppressor
cytokin
signal
soc
fig
known
upregul
follow
hpai
infect
cell
rna
sampl
store
volum
sodium
acet
depctreat
water
volum
ethanol
submit
macrogen
inc
seoul
republ
korea
hiseq
analysi
sequenc
analysi
annot
confirm
checksum
assess
raw
data
qualiti
fastq
file
fastqc
rnaseq
read
process
accord
standard
tuxedo
pipelin
protocol
use
annot
human
genom
download
illumina
igenom
refer
briefli
raw
read
sampl
map
human
genom
use
sort
convert
sam
format
use
samtool
assembl
transcriptom
use
cufflink
cuffmerg
use
combin
transcript
annot
individu
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
sampl
singl
refer
transcriptom
cuffquant
use
obtain
persampl
read
count
cuffdiff
use
conduct
differenti
express
analysi
program
run
use
recommend
paramet
howev
refer
gtf
file
provid
cuffmerg
first
edit
use
custom
python
script
exclud
line
contain
featur
exoncd
contig
chromosom
x
gene
ontolog
go
kegg
enrich
offici
gene
id
transcript
differenti
modul
follow
hpai
infect
without
apocynin
treatment
compil
three
target
list
statist
signific
differenti
express
transcript
defin
chang
benjaminihochberg
adjust
p
valu
background
list
gene
compil
retriev
gene
id
identifi
present
hiseq
analysi
fpkm
biolog
process
go
enrich
perform
use
gorilla
compar
unrank
background
target
list
redund
go
term
remov
use
revigo
target
list
also
subject
kegg
pathway
analysi
use
basic
kegg
pathway
mapper
tabl
design
estim
express
variant
atii
cell
use
itaq
univers
sybr
green
supermix
biorad
accord
manufactur
instruct
absenc
nonspecif
amplif
confirm
agaros
gel
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
electrophoresi
qrtpcr
product
gene
express
normal
mrna
use
method
express
level
determin
rel
uninfect
cell
control
qrtpcr
primer
primer
pair
use
identifi
variant
list
tabl
cell
adhes
molecul
immunoglobulin
superfamili
human
lymphocyt
structur
express
involv
cell
activ
eur
j
immunol
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
chemokin
product
respons
infect
moi
hpi
qrtpcr
pare
sinegtransfect
control
cell
one
sampl
test
compar
sinegtransfect
cell
foldchang
p
p
plaqu
assay
viru
titr
atii
c
either
mocktransfect
transfect
sineg
p
p
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
tabl
repres
overrepres
kegg
pathway
number
gene
contribut
pathway
significantli
upregul
follow
infect
nd
vs
hd
number
gene
pathway
express
significantli
lower
level
ha
group
also
list
fig
nd
vs
hd
hd
vs
ha
full
list
overrepres
kegg
pathway
present
tabl
rigilik
receptor
signal
pathway
cell
adhes
molecul
cam
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
